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Green synthesisAbstract A series of (E)-2-[5-chloro-1-(1H-benzo[d]imidazol-2-yl)ethylidene] N-(substituted)
hydrazine carbothioamide (7a–7t) and (E)-2-[1-(1H-benzo[d]imidazol-2-yl)ethylidene] N-(substi-
tuted) hydrazine carbothioamide (8a–8t) were prepared via the synthesis of 1-(substituted-1
H-benzimidazol-2-yl) ethanol (3a–3b) which was synthesized by the condensation of substituted
o-phenylenediamine (2a–2b) with DL-lactic acid (1) followed by oxidation with sodium hypochlorite
in mild acidic condition to form the corresponding ketones 4a–4b. Final compounds were formed
by condensation of 4a–4b with different thiosemicarbazides 6a–6t. A total of 40 compounds were
synthesized and characterized by FT-IR, 1H NMR, 13C NMR, Mass spectral technique and elemen-
tal analysis, in addition they were evaluated for anti-malarial properties. Among the compounds
tested 7o, 7p, 7q, 7r, 7s, 8e and 8h exhibited good antimalarial activity in vitro.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Malaria is endemic in over 100 countries, affecting especially
tropical areas of Africa, Asia and Latin America. It is respon-
sible for high mortality and morbidity in these regions, being
especially lethal to children and pregnant women. (De
Oliveira et al., 2008) According to World Health Organizationup to one million people die of malaria worldwide, every year
(WHO, Geneva, 2006). Human malaria is caused by four dif-
ferent species of Plasmodium: Plasmodium falciparum, Plasmo-
dium vivax, Plasmodium ovale and Plasmodium malariae. The
most severe form is caused by P. falciparum, which leads to
the death of about 1% of infected patients. Although the use
of drugs has effectively resulted in successful treatment of Plas-
modium infections, drug resistances in Plasmodium have been
reported (Bloland, 2001; Gogtay et al., 2006; Kshirsagar,
2006). Owing to growing resistance, the development of potent
antimalarials is recommended to fulﬁl this challenge. Recently
there have been a lot of studies using iron-chelating agents as a
possible treatment for malaria (Cabantchik, 1994;
Kontoghiorghes et al., 2010). Thiosemicarbazones are known
iron-chelating agents by bonding through the sulphur andial activ-
2 S.M. Divatia et al.azomethine nitrogen atoms (Walcourt et al., 2004). Their activ-
ity against extracellular protozoan such as P. falciparum,
Trichomonas vaginalis, Trypanosoma cruzi, and other parasites
was demonstrated by several researchers (Bharti et al., 2002;
Greenbaum et al., 2004).
On the other hand, the structural similarities between
benzimidazole nucleus and various biological compounds such
as purine base of the DNA and its presence in vitamin B12 have
made it important in the pharmaceutical industry. As a result of
this, benzimidazoles have been termed as key structures for
drug design (Panda et al., 2012). Thus, because of its increasing
medicinal importance, great efforts have been made to develop
an efﬁcient and economical method for the synthesis of its large
number of new derivatives. This inspired us to study the biolog-
ical activities of thiosemicarbazone analogues of benzimid-
azole. In this research article, we have reported the synthesis
of new benzimidazole-thiosemicarbazone derivatives. These
compounds were tested for in vitro antimalarial screening.
2. Materials and methods
2.1. Chemistry
Melting points were determined on a Bu¨chi 535 melting point
apparatus and are uncorrected. A CEM Discover microwave
synthesizer (Model No. 908010) operating at 180/264 V and
50/60 Hz with a microwave power maximum level of 700 W
and microwave frequency of 2455 MHz was employed for
microwave-assisted experiments done in this work. Infrared
spectra were recorded on a Perkin-Elmer 841 using samples
in potassium bromide discs. The 1H NMR and 13C NMR spec-
tra were recorded on a Bruker 400 MHz spectrometer using
DMSO-d6 as a solvent and TMS as an internal standard. Mass
spectra were recorded on a TSQ-Quantum Access Mass spec-
trometer by ESI (electron spray ionization) method. Elemental
analyses were performed on a Micro Variant CHN elemental
analyser. TLC was performed on a Merck DC Alufolien with
Kieselgel 60F254 from Merck Co., Germany. All the raw-
materials were purchased from Sigma–Aldrich Co, Germany.
2.1.1. Synthesis of 1-(5-Chloro-1H-benzimidazol-2-yl) ethanol
(3a) (Patel et al., 2013)
In a 50 mL glass round bottomed ﬂask, 4-Chlorobenzene-1,2-
diamine (2a) (0.003 mmol) and D,L-lactic acid (1) (88%
approx.) (8 mL) were mixed. To this mixture, ethylene glycol
(5 mL) was added. The reaction mixture was heated by an
open vessel method in the Discover Microwave Synthesizer
(CEM Matthews Inc., USA) at 300 W with total irradiation
time of 35 min. On cooling, the reaction mixture was treated
with a saturated solution of NaHCO3. (pH 8). After neutral-
ization, the residue obtained was dissolved in methanol and ﬁl-
tered. The ﬁltrate was concentrated to dryness. The residue
was then collected by ﬁltration as a yellow solid form. The
yield was 78% and product was further used after crystalliza-
tion from alcohol, m.p. was taken at 168–170 C. Reaction
progress was checked by TLC plates using ethyl acetate: tolu-
ene (4:1) as the mobile phase. IR (KBr): 3360 (NH), 3077 (C–H
benzene), 1599 (C‚C & C‚N), 1113 (C–O)cm1; 1H NMR
(400 MHz, DMSO-d6): d 1.49–1.51 (d, 3H, J= 8 Hz,CH3),
4.68–4.75 (m, 1H, CH), 5.77–5.79 (d, 1H, J= 8 Hz, OH),
7.14–7.16 (d, 1H, J= 8 Hz, Ar-H), 7.80–7.82 (d, 1H,Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09J= 7.9 Hz, Ar-H), 8.38–8.41 (d, 1H, J= 8.9 Hz, Ar-H),
13.05 (s, 1H, NH). HRMS (m/z, ESI): M+ 196.05, [M+2]
198.05. Anal. Calcd. for C9H9ClN2O (Mol. Wt. 196.63): C,
54.97; H, 4.61; N, 14.25. Found: C, 54.94; H, 4.58; N, 14.23.%.
2.1.1.1. Synthesis of 1-(1H-benzimidazol-2-yl) ethanol (3b).
Similarly, we have synthesized compound (3b) by taking com-
pound (2b) as a starting material. The product was isolated as
a light yellow solid with 75% yield and m.p. was taken at 165–
167 C. IR (KBr): 3420 (NH), 3107 (C–H benzene), 1492
(C‚C & C‚N), 1125 (C–O)cm1; 1H NMR (400 MHz,
DMSO-d6): d 1.56–1.58 (d, 3H, J= 8 Hz, CH3), 4.75–4.84
(m, 1H, CH), 5.68–5.70 (d, 1H, J= 8 Hz, OH), 7.25–7.27 (d,
1H, J= 8 Hz, Ar-H), 7.35–7.40 (t, 1H, J= 7.5 Hz, Ar-H),
8.52–8.54 (d, 1H, J= 8 Hz, Ar-H), 12.96 (s, 1H, NH). HRMS
(m/z, ESI): M+ 162.10, [M+1] 163.10. Anal. Calcd. for
C9H10N2O (Mol. Wt. 162.19): C, 66.65; H, 6.21; N, 17.27.
Found: C, 66.62; H, 6.18; N, 17.25.%.
2.1.2. Synthesis of 1-(5-chloro-1H-benzimidazol-2-yl) ethanone
(4a)
To a solution of 1-(5-chloro-1H-benzimidazol-2-yl) ethanol
(3a) (0.001 mmol) in glacial acetic acid (10 mL) was added
gradually a solution of 4% sodium hypochlorite solution
(NaOCl) (0.0013 mmol/25 mL) in an ice bath because of the
exothermic reaction. After addition of NaOCl, the reaction
mixture was stirred for 20 min at room temperature. It was
necessary to stir the mixture vigorously as the reaction mixture
was two-phased. The reaction mixture was then tested for
excess hypochlorite with starch-iodide paper. The addition of
0.5 mL of a saturated sodium bisulphite (Na2SO3) solution
was done to remove the blue-black color. The mixture was
swirled after addition and then tested again until the complete
removal of hypochlorite. After that the reaction was neutral-
ized with the help of 6 M NaOH. The product was then
obtained via the extraction process. In a separating funnel,
product was extracted with 3 · 5 mL portions of methylene
dichloride (CH2Cl2). An aqueous layer was removed and the
combined organic layer was dried with Na2SO4 for about 5–
10 min with occasional stirring and then sodium sulphate
was isolated with Buchner funnel. The remaining organic
extract was taken in a rotary evaporator to remove the solvent
under reduced pressure. The yellow precipitates were collected
in 75% yield and dried further. The product started decompos-
ing before reaching its M.P. The reaction progress was checked
by TLC using Ethyl acetate: Toluene (4:1) as solvents; IR
(KBr): 3368 (NH), 3060 (C–H benzene), 1699 (C‚O) cm1;
1H NMR (400 MHz, DMSO-d6): d 2.70 (s, 3H, CH3), 7.35–
7.39 (d, 1H, J= 8 Hz, Ar-H), 7.78–7.80 (d, 1H, J= 8 Hz,
Ar-H), 8.24 (s, 1H, Ar-H), 13.5 (s, 1H, NH). HRMS (m/z,
ESI): M+ 194.02, [M+2] 196.05. Anal. Calcd. for C9H7ClN2O
(Mol. Wt. 194.62): C, 55.54; H, 3.63; N, 14.39. Found: C,
55.50; H, 3.60; N, 14.36.%.
2.1.2.1. Synthesis of 1-(1H-benzimidazol-2-yl) ethanone (4b).
Similarly, 1-(1H-benzimidazol-2-yl) ethanone (4b) was
synthesized by taking 1-(1H-benzimidazol-2-yl) ethanol (3b)
as a starting material. The yellow precipitates were obtained
in 76% yield. The product started decomposing before reach-
ing its M.P. IR (KBr): 3375 (N–H), 3054 (C–H benzene), 1685
(C‚O) cm1; 1H NMR (400 MHz, DMSO-d6): d 2.48 (s, 3H,atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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Green synthesis of thiosemicarbazone derivatives 3CH3), 7.28–7.30 (d, 1H, J= 8 Hz, Ar-H), 7.68–7.70 (d,
J= 8 Hz, Ar-H), 8.50 (s, 1H, Ar-H), 13.28 (s, 1H, NH).
HRMS (m/z, ESI): M+ 160.06, [M+1] 161.07. Anal. Calcd.
for C9H8N2O (Mol. Wt. 160.17): C, 67.49; H, 5.03; N, 17.49.
Found: C, 67.46; H, 5.00; N, 17.47.%.
2.1.3. General procedure for the synthesis of N4-alkyl and aryl
thiosemicarbazides (6a–6t)
The alkyl or aryl isothiocyanate (0.001 mmol) was added drop-
wise in a solution of hydrazine (0.001 mmol) in methanol
(6 mL). The reaction was irradiated by microwaves in a Dis-
cover Microwave Synthesizer (CEM Matthews Inc., USA) at
180 W with a total irradiation time of 3–5 min. The excess sol-
vent was then removed by evaporation in vacuo and the crude
product was dissolved in chloroform (5 mL) and this solution
was added into multifold volume of petroleum ether
(40–60 C) at constant stirring. The precipitates obtained were
used directly for the next step. All thiosemicarbazides (6a–6t)
were obtained by the general method described above.
2.1.4. General procedure illustrating the synthesis of (E)-2-[1-
(5-chloro-1H-benzo[d]imidazol-2-yl)ethylidene] N-hydrazine
carbothioamide (7a–7t)
An alkyl or aryl thiosemicarbazide (6a–6t) (0.001 mmol) and
10 drops of glacial acetic acid were added to a solution of 1-
(5-chloro-1H-benzimidazol-2-yl) ethanone (4a) in methanol
(6 mL). The reaction mass was heated in a Discover
Microwave Synthesizer (CEM Matthews Inc., USA) at
180 W with a total irradiation time of 25–35 min. The product
was obtained upon cooling, and then dried. The reaction pro-
gress was checked by TLC taking Ethyl acetate: Toluene (4:1)
as the mobile phase. The product was re-crystallized by 95%
ethanol. The product was obtained as a brown colored solid
in good yield which was further characterized by FT-IR, 1H
NMR, Mass spectra and elemental analysis. A series of all
compounds (7a–7t) were synthesized by the above described
method.
2.1.4.1. (E)-2-(1-[5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] hydrazine carbothioamide (7a) (Patel et al., 2013).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 25 min. The product was a light brown
solid; 75% yield; m.p. 214–215 C; IR (cm1, KBr): 3454 (–
NH), 1213 (C‚S), 1531 (C‚N), 1584 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.38 (s, 3H, –CH3), 7.07–7.55 (m,
1H, Ar-H), 7.67–7.65 (d, 1H, J= 7.6 Hz, Ar-H), 7.92 (s, 1H,
Ar-H), 8.57 (s, 2H, –NH2), 10.73 (s, 1H, –NH), 12.88 (s, 1H,
–NH); 13C NMR (100 MHz, DMSO-d6) Benzimidazole C:
[152.65 (C), 140.48 (C), 138.89 (C), 130.07 (C–Cl), 126.56
(CH), 117.29 (CH), 116.34 (CH)], 180.34 (C‚S), 157.60
(N‚CH), 25.46 (CH3); HRMS (m/z, ESI): M
+ 267.03,
[M+2] 269.03. Anal. Calcd. for C10H10ClN5S (Mol. Wt.
267.73): C, 44.86; H, 3.76; N, 26.12. Found: C, 44.84; H,
3.73; N, 26.10%.
2.1.4.2. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-phenylhydrazine carbothioamide (7b) (Patel et al.,
2013). The reaction mass was heated in MW at 180 W with a
total irradiation time of 35 min. The product was a light brown
solid; 85% yield; m.p. at 161–162 C; IR (cm1, KBr): 3205
(NH), 1189 (C‚S), 1514 (C‚N), 1596 (C‚C); 1H NMRPlease cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
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1H, J= 8 Hz, Ar-H), 7.40–7.44 (t, 1H, J= 7.9 Hz, Ar-H),
7.49–7.51 (d, 1H, J= 8 Hz, Ar-H), 7.59–7.64 (d, 1H,
J= 7.6 Hz, Ar-H), 8.36 (s, 1H, Ar-H), 10.40 (s, 1H, NH),
11.07 (s, 1H, NH), 13.02 (s, 1H, NH); 13C NMR (100 MHz,
DMSO-d6) Benzimidazole C: [152.45 (C), 140.28 (C), 137.39
(C), 130.17 (C–Cl), 126.78 (CH), 117.56 (CH), 116.49 (CH)],
Arom-C: [140.33 (C), 127.58 (CH), 128.44 (C), 129.26 (CH),
184.34 (C‚S), 156.58 (N‚CH), 25.50 (CH3); HRMS (m/z,
ESI): M+ 342.9, [M+2] 344.9. Anal. Calcd. for C16H14ClN5S
(Mol. Wt. 343.83): C, 55.89; H, 4.10; N, 20.37. Found: C,
55.87; H, 4.06; N, 20.33%.
2.1.4.3. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-ethylhydrazine carbothioamide (7c) (Patel et al.,
2013). The reaction mass was heated in MW at 180 W with a
total irradiation time of 25 min. The product was a light
Brown solid; 83% yield; m.p. 223–224 C; IR (cm1, KBr):
3435 (NH), 1199 (C‚S), 1492 (C‚N), 1549 (C‚C); 1H
NMR (400 MHz, DMSO-d6): d 2.38–2.46 (s, 3H, CH3),
1.16–1.20 (t, 3H, J= 6.8 Hz, CH2), 3.66–3.68 (t, 2H,
J= 6.8 Hz, CH3), 7.24 (d, 1H, J= 7.5 Hz, Ar-H), 7.55 (d,
1H, J= 7.5 Hz, Ar-H), 7.70 (s, 1H, Ar-H), 8.96 (s, 1H,
NH), 10.68 (s, 1H, NH), 12.82 (s, 1H, NH); 13C NMR
(100 MHz, DMSO-d6) Benzimidazole C: [152.25 (C), 139.98
(C), 137.86 (C), 130.53 (C–Cl), 126.95 (CH), 117.87 (CH),
116.93 (CH)], 180.15 (C‚S), 156.45 (N‚CH), 42.50 (CH2),
25.48(CH3), 28.56 (CH3); HRMS (m/z, ESI): M
+ 296.10,
[M+2] 298.10. Anal. Calcd. for C12H14ClN5S (Mol. Wt.
295.79): C, 48.73; H, 4.77; N, 23.68. Found: C, 48.71; H,
4.75; N, 23.65.%.
2.1.4.4. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-(n-butyl) hydrazine carbothioamide (7d) (Patel
et al., 2013). The reaction mass was heated in MW at 180 W
with a total irradiation time of 25 min. The product was a
brown solid; 69% yield; m.p. 203–204 C; IR (cm1, KBr):
3448 (NH), 1216 (C‚S), 1419 (C‚N), 1541 (C‚C); 1H
NMR (400 MHz, DMSO-d6): d 0.88–0.91 (t, 3H, J= 6.8 Hz,
CH3), 1.30–1.35 (m, 2H, CH2), 1.57–1.87 (m, 2H, CH2),
2.40–2.42 (t, 1H, J= 7.9 Hz, CH2), 3.62 (s, 2H, CH3), 7.27–
7.28 (d, 1H, J= 7.5 Hz, Ar-H), 7.55 (d, 1H, J= 7.8 Hz, Ar-
H), 7.71 (s, 1H, Ar-H), 8.94 (s, 1H, NH), 10.68 (s, 1H, NH),
12.83 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6) Benz-
imidazole C: [152.30 (C), 140.25 (C), 137.97 (C), 130.32
(C–Cl), 126.92 (CH), 117.85 (CH), 116.96 (CH)], 179.45
(C‚S), 156.66 (N‚CH), Butyl C: [48.76 (CH2), 42.59
(CH2), 31.48(CH2)], 25.56 (CH3); HRMS (m/z, ESI): M
+
323.04, [M+2] 325.04. Anal. Calcd. for C14H18ClN5S (Mol.
Wt. 323.84): C, 51.92; H, 5.60; N, 21.63. Found: C, 51.90;
H, 5.58; N, 21.61%.
2.1.4.5. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-cyclohexyl hydrazine carbothioamide (7e) (Patel
et al., 2013). The reaction mass was heated in MW at 180 W
with a total irradiation time of 25 min. The product was a
brown solid; 85% yield; m.p. 215–216 C; IR (cm1, KBr):
3420 (NH), 1206 (C‚S), 1519 (C‚N), 1594 (C‚C); 1H
NMR (400 MHz, DMSO-d6):d 1.22–1.89 (m, 11H, Cyclohex-
H), 2.40–2.46 (s, 3H, CH3), 7.28–7.31 (d, 1H, J= 7.9 Hz,
Ar-H), 7.51–7.53 (d, 1H, J= 8 Hz, Ar-H), 7.71–7.77
(s, 1H, Ar-H), 9.80 (s, 1H, NH), 10.55 (s, 1H, NH), 13.10 (s,atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
.007
4 S.M. Divatia et al.1H, NH); 13C NMR (100 MHz, DMSO-d6): d Benzimidazole
C: [152.36 (C), 140.28 (C), 137.98 (C), 130.38 (C–Cl), 126.96
(CH), 117.75 (CH), 116.87 (CH)], 179.15 (C‚S), 156.68
(N‚CH), Cyclohexyl C: [60.05 (CH), 42.15 (CH2), 35.19
(CH2), 35.05 (CH2)], 25.66 (CH3); HRMS (m/z, ESI): M
+
349.11, [M+2] 351.11. Anal. Calcd. for C16H20ClN5S (Mol.
Wt. 349.88): C, 54.92; H, 5.76; N, 20.02. Found: C, 54.90;
H, 5.74; N, 20.00%.
2.1.4.6. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-(4-chlorophenyl) hydrazine carbothioamide (7f). The
reaction mass was heated in MW at 180 W with a total irradi-
ation time of 30 min. The product was a brown solid; 77%
yield; m.p. 178–180 C; IR (cm1, KBr): 3375 (NH), 1215
(C‚S), 1560 (C‚N), 1620 (C‚C); 1H NMR (400 MHz,
DMSO-d6):d 2.50 (s, 3H, CH3), 7.26–7.28 (d, 1H, J= 8 Hz,
Ar-H), 7.33–7.35 (d, 1H, J= 8 Hz, Ar-H), 7.53–7.55 (d, 1H,
J= 8 Hz, Ar-H), 7.59–7.61 (d, 1H, J= 8.5 Hz, Ar-H), 7.75–
7.77 (d, 1H, J= 8 Hz, Ar-H), 7.89 (s, 1H, Ar-H), 10.46 (s,
1H, NH), 11.25 (s, 1H, NH), 13.15 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [152.34 (C),
140.42 (C), 137.60 (C), 130.30 (C–Cl), 126.52 (CH), 117.32
(CH), 116.34 (CH)], 184.36 (C‚S), 157.22 (N‚CH), Arom-
C: [144.48 (C), 142.54 (C–Cl), 128.78 (CH, CH), 127.88
(CH,CH)], 25.54 (CH3); HRMS (m/z, ESI): M
+ 378.03,
[M+2] 380.03. Anal. Calcd. for C16H13Cl2N5S (Mol. Wt.
378.28): C, 50.80; H, 3.46; N, 18.51. Found: C, 50.00; H,
3.43; N, 18.43%.
2.1.4.7. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-(4-nitrophenyl) hydrazine carbothioamide (7g). The
reaction mass was heated in MW at 180 W with a total irradi-
ation time of 35 min. The product was a brown solid; 75%
yield; m.p. 205–208 C; IR (cm1, KBr): 3320 (NH), 1195
(C‚S), 1525 (C‚N), 1605 (C‚C); 1H NMR (400 MHz,
DMSO-d6): d 2.68 (s, 3H, CH3), 7.39–7.41 (d, 1H, J= 8 Hz,
Ar-H), 7.72–7.74 (d, 1H, J= 8 Hz, Ar-H), 7.84–7.86 (d, 1H,
J= 8 Hz, Ar-H), 8.04–8.06 (d, 1H, J= 8 Hz, Ar-H), 8.20 (s,
1H, Ar-H), 9.62 (s, 1H, NH), 10.77 (s, 1H, NH), 13.07 (s,
1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benzimidazole
C: [152.26 (C), 140.38 (C), 137.58 (C), 130.28 (C–Cl), 126.44
(CH), 117.25 (CH), 116.27 (CH)], 184.25 (C‚S), 157.08
(N‚CH), Arom-C: [144.60 (C), 125.16 (CH, CH), 125.78
(CH, CH), 143.94 (C–NO2)], 25.56 (CH3); HRMS (m/z,
ESI): M+ 388.03, [M+2] 390.03. Anal. Calcd. for C16H13-
ClN6O2S (Mol. Wt. 388.83): C, 49.42; H, 3.37; N, 21.61.
Found: C, 49.38; H, 3.33; N, 21.58%.
2.1.4.8. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-(4-methoxyphenyl) hydrazine carbothioamide (7h).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
75% yield; m.p. 192–194 C; IR (cm1, KBr): 3350 (NH),
1215 (C‚S), 1570 (C‚N), 1630 (C‚C), 1274 (C–O–C); 1H
NMR (400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 3.80 (s,
3H, OCH3), 6.86–6.88 (d, 1H, J= 8 Hz, Ar-H), 7.26–7.28
(d, 1H, J= 8 Hz, Ar-H), 7.33–7.35 (d, 1H, J= 8 Hz, Ar-H),
7.73–7.76 (d, 1H, J= 8 Hz, Ar-H), 7.82 (s, 1H, Ar-H), 10.38
(s, 1H, NH), 11.07 (s, 1H, NH), 13.15 (s, 1H, NH). 13CPlease cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09NMR (100 MHz, DMSO-d6): d Benzimidazole C: [152.28
(C), 140.41 (C), 137.62 (C), 130.30 (C–Cl), 126.48 (CH),
117.28 (CH), 116.30 (CH)], 184.28 (C‚S), 157.18 (N‚CH),
Arom-C: [160.10 (C), 132.48 (C), 127.96 (CH, CH), 114.85
(CH, CH)], 59.25 (OCH3), 25.56 (CH3); HRMS (m/z, ESI):
M+ 373.12, [M+2] 375.12. Anal. Calcd. for C17H16ClON5S
(Mol. Wt. 373. 85): C, 54.61; H, 4.31; N, 18.73. Found: C,
50.43; H, 4.29; N, 18.71%.
2.1.4.9. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyli-
dene] N-(isopropyl) hydrazine carbothioamide (7i). The reac-
tion mass was heated in MW at 180 W with a total
irradiation time of 25 min. The product was a brown solid;
72% yield; m.p. 220–222 C; IR (cm1, KBr): 3373 (NH),
2974(C(CH3)), 1220 (C‚S), 1580 (C‚N), 1620 (C‚C);
1H
NMR (400 MHz, DMSO-d6): d 1.27–1.29 (d, 6H,
J= 8 Hz,(CH3)2), 2.56 (s, 3H, CH3), 4.25–4.30 (m, 1H, CH),
7.12–7.14 (d, 1H, J= 8 Hz, Ar-H), 7.38–7.40 (d, 1H,
J= 8 Hz, Ar-H), 7.82 (s, 1H, Ar-H), 10.55 (s, 1H, NH),
11.17 (s, 1H, NH), 13.25 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [152.44 (C), 140.48 (C),
137.70 (C), 130.56 (C–Cl), 126.52 (CH), 117.34 (CH), 116.47
(CH)], 178.58 (C‚S), 157.35 (N‚CH), Isopropyl C: [52.10
(CH), 33.24 (CH3, CH3)], 25.35 (CH3); HRMS (m/z, ESI):
M+ 309.11, [M+2] 311.11. Anal. Calcd. for C13H16ClN5S
(Mol. Wt. 309.81): C, 50.40; H, 5.21; N, 22.60. Found: C,
50.37; H, 5.19; N, 22.57%.
2.1.4.10. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(tert-butyl) hydrazine carbothioamide (7j). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 25 min. The product was a brown solid; 85% yield;
m.p. 211–214 C; IR (cm1, KBr): 3298 (NH), 1235 (C‚S),
1565 (C‚N), 1593 (C‚C); 1H NMR (400 MHz, DMSO-d6):
d 1.52–1.68 (m, 9H, (CH3)3), 2.64 (s, 3H, CH3), 7.08–7.10 (d,
1H, J= 8 Hz, Ar-H), 7.28–7.31 (d, 1H, J= 7.9 Hz, Ar-H),
7.74 (s, 1H, Ar-H), 9.46 (s, 1H, NH), 12.77 (s, 1H, NH),
13.53 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benz-
imidazole C: [152.45 (C), 140.48 (C), 137.76 (C), 130.66 (C–
Cl), 126.58(CH), 117.58 (CH), 116.67 (CH)], 178.38 (C‚S),
157.55 (N‚CH), t-butyl C: [62.36 (C), 40.26 (CH3, CH3,
CH3)], 25.30 (CH3); HRMS (m/z, ESI): M
+ 323.15, [M+2]
325.15. Anal. Calcd. for C14H18ClN5S (Mol. Wt. 323.84): C,
51.92; H, 5.60; N, 21.63. Found: C, 51.89; H, 5.58; N, 21.60%.
2.1.4.11. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(benzyl) hydrazine carbothioamide (7k). The reac-
tion mass was heated in MW at 180 W with a total
irradiation time of 35 min. The product was a brown solid;
65% yield; m.p. 218–219 C; IR (cm1, KBr): 3379 (NH),
1236 (C‚S), 1546 (C‚N), 1583 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 4.72 (s, 2H,
CH2), 7.23–7.75 (m, 5H, Ar-H), 8.31 (s, 1H, Ar-H), 9.70 (s,
1H, NH), 11.03 (s, 1H, NH), 13.13 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [152.48 (C),
140.52 (C), 137.78 (C), 130.60 (C–Cl), 126.58(CH), 117.57
(CH), 116.69 (CH)], 178.45 (C‚S), 157.58 (N‚CH), Arom-
C: [138.72 (C), 129.95 (CH, CH), 127.30 (CH, CH), 126.98
(C)], 55.34 (CH2), 25.25 (CH3); HRMS (m/z, ESI): M
+atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
.007
Green synthesis of thiosemicarbazone derivatives 5357.26, [M+2] 359.26. Anal. Calcd. for C17H16ClN5S (Mol.
Wt. 357.86): C, 57.06; H, 4.51; N, 19.57. Found: C, 57.00;
H, 4.48; N, 19.55%.
2.1.4.12. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(2,4-dichlorophenyl) hydrazine carbothioamide (7l).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
68% yield; m.p. 180–182 C; IR (cm1, KBr): 3375 (NH),
1242 (C‚S), 1543 (C‚N), 1581 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.50 (s, 3H, CH3), 7.27 (d, 1H,
J= 8.5 Hz, Ar-H), 7.40–7.44 (d, 1H, J= 8.5 Hz, Ar-H),
7.66–7.68 (d, 1H, J= 7.9 Hz, Ar-H), 7.88–7.90 (d, 1H,
J= 7.9 Hz, Ar-H), 8.37 (s, 1H, Ar-H), 8.42 (s, 1H, NH),
9.85 (s, 1H, NH), 10.68 (s, 1H, NH), 13.09 (s, 1H, NH). 13C
NMR (100 MHz, DMSO-d6): d Benzimidazole C: [152.42
(C), 140.48 (C), 137.75 (C), 130.58 (C–Cl), 126.63(CH),
117.62 (CH), 116.74 (CH)], 185.28 (C‚S), 157.63 (N‚CH),
Arom-C: [135.60 (C), 134.23 (C–Cl), 133.86 (CH), 133.18
(C–Cl), 132.54 (CH), 125.58 (CH)], 25.32 (CH3); HRMS (m/
z, ESI): M+ 412.28, [M+2] 414.28. Anal. Calcd. for
C16H12Cl3N5S (Mol. Wt. 412.72): C, 46.56; H, 2.93; N,
16.97. Found: C, 46.54; H, 2.90; N, 16.95%.
2.1.4.13. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(2-methoxyphenyl) hydrazine carbothioamide (7m).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
72% yield; m.p. 192–193 C; IR (cm1, KBr): 3312 (NH),
1204 (C‚S), 1597 (C‚N), 1620 (C‚C), 1274 (C–O–C); 1H
NMR (400 MHz, DMSO-d6): d 2.50 (s, 3H, CH3), 3.84 (s,
3H, OCH3), 6.90–7.26 (m, 4H, Ar-H), 7.42–7.50 (t, 1H,
J= 8 Hz, Ar-H), 8.29 (s, 1H, Ar-H), 9.22 (s, 1H, NH),
10.27 (s, 1H, NH), 13.15 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [152.42 (C), 140.44 (C),
137.76 (C), 130.56 (C–Cl), 126.66(CH), 117.65 (CH), 116.74
(CH)], 185.15 (C‚S), 156.93 (N‚CH), Arom-C: [154.60
(C), 130.12 (C), 128.43 (CH), 127.98 (CH), 124.34 (CH),
119.38 (CH)], 58.64 (OCH 3), 25.25 (CH3); HRMS (m/z,
ESI): M+ 373.15, [M+2] 375.15. Anal. Calcd. for
C17H16ClON5S (Mol. Wt. 373. 85): C, 54.61; H, 4.31; N,
18.73. Found: C, 50.43; H, 4.29; N, 18.71%.
2.1.4.14. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(3-methoxyphenyl) hydrazine carbothioamide (7n).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
70% yield; m.p. 190–192 C; IR (cm1, KBr): 3277 (NH),
1202 (C‚S), 1562 (C‚N), 1610 (C‚C), 1280 (C–O–C); 1H
NMR (400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 3.81 (s,
3H, OCH3), 6.77–6.97 (m, 3H, Ar-H), 7.01–7.13 (t, 1H,
J= 7.9 Hz, Ar-H), 7.21–7.50 (m, 2H, Ar-H), 7.66–7.68 (d,
1H, J= 8 Hz, Ar-H), 7.97 (s, 1H, Ar-H), 10.26 (s, 1H, NH),
11.25 (s, 1H, NH), 13.15 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [152.43 (C), 140.46 (C),
137.74 (C), 130.52 (C–Cl), 126.69(CH), 117.59 (CH), 116.76
(CH)], 185.26 (C‚S), 156.98 (N‚CH), Arom-C: [160.90
(C), 138.24 (C), 130.03 (CH), 120.18 (CH), 121.54 (CH),
119.35 (CH)], 58.67 (OCH 3), 25.22 (CH3); HRMS (m/z,
ESI): M+ 373.36, [M+2] 375.36. Anal. Calcd. for
C17H16ClON5S (Mol. Wt. 373. 85): C, 54.61; H, 4.31; N,
18.73. Found: C, 50.43; H, 4.29; N, 18.71%.Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.092.1.4.15. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(benzoyl) hydrazine carbothioamide (7o). The reac-
tion mass was heated in MW at 180 W with a total
irradiation time of 35 min. The product was a brown solid;
65% yield; m.p. 203–204 C; IR (cm1, KBr): 3136 (NH),
1224 (C‚S), 1577 (C‚N), 1616 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 7.46 (d, 1H,
J= 7.9 Hz, Ar-H), 7.52 (d, 1H, J= 8 Hz, Ar-H), 7.82–7.92
(t, 1H, J= 8 Hz, Ar-H), 8.02 (s, 1H, Ar-H), 9.89 (s, 1H,
NH), 13.71 (s, 1H, NH), 13.95 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [152.35 (C),
140.54 (C), 137.64 (C), 130.48 (C–Cl), 126.55(CH), 117.49
(CH), 116.66 (CH)], 184.22 (C‚S), 165.77 (C‚O), 156.85
(N‚CH), Arom-C: [135.23 (C), 134.84 (CH), 130.37 (CH,
CH), 127.68 (CH, CH)], 25.33 (CH3); HRMS (m/z, ESI):
M+ 371.06, [M+2] 373.06. Anal. Calcd. for C17H14ClON5S
(Mol. Wt. 371. 86): C, 54.91; H, 3.79; N, 18.83. Found: C,
54.37; H, 3.77; N, 18.80%.
2.1.4.16. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(4-ﬂuorophenyl) hydrazine carbothioamide (7p). The
reaction mass was heated in MW at 180 W with a total irradi-
ation time of 30 min. The product was a brown solid; 75%
yield; m.p. 195–197 C; IR (cm1, KBr): 3246 (NH), 1217
(C‚S), 1583 (C‚N), 1618(C‚C); 1H NMR (400 MHz,
DMSO-d6): d 2.51 (s, 3H, CH3), 6.54–6.83 (m, 2H, Ar-H),
7.13–7.15 (d, 1H, J= 8 Hz, Ar-H), 7.42–8.05 (m, 4H, Ar-H),
9.38 (s, 1H, NH), 10.07 (s, 1H, NH), 13.03 (s, 1H, NH). 13C
NMR (100 MHz, DMSO-d6): d Benzimidazole C: [152.40
(C), 140.55 (C), 137.68 (C), 130.51 (C–Cl), 126.58 (CH),
117.52 (CH), 116.67 (CH)], 184.30 (C‚S), 156.95 (N‚CH),
Arom-C: [165.35 (C–F), 135.18 (C), 130.27 (CH, CH), 116.68
(CH, CH)], 25.36 (CH3); HRMS (m/z, ESI): M
+ 361.25,
[M+2] 363.25. Anal. Calcd. for C16H13ClFN5S (Mol. Wt.
361.82): C, 53.11; H, 3.62; N, 19.36. Found: C, 53.08; H,
3.60; N, 19.33%.
2.1.4.17. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(4-iodophenyl) hydrazine carbothioamide (7q). The
reaction mass was heated in MW at 180 W with a total irradi-
ation time of 35 min. The product was a brown solid; 78%
yield; m.p. 198–199 C; IR (cm1, KBr): 3246 (NH), 1218
(C‚S), 1583 (C‚N), 1616 (C‚C); 1H NMR (400 MHz,
DMSO-d6): d 2.51 (s, 3H, CH3), 6.40–6.42 (d, 1H, J= 8 Hz,
Ar-H), 7.15–7.27 (m, 2H, Ar-H), 7.43–7.87 (m, 2H, Ar-H),
7.95–7.98 (d, 1H, J= 7.9 Hz, Ar-H), 8.29 (s, 1H, Ar-H),
9.25 (s, 1H, NH), 11.37 (s, 1H, NH), 13.14 (s, 1H, NH). 13C
NMR (100 MHz, DMSO-d6): d Benzimidazole C: [152.45
(C), 140.44 (C), 137.75 (C), 130.48 (C–Cl), 126.53 (CH),
117.57 (CH), 116.71 (CH)], 184.05 (C‚S), 156.98 (N‚CH),
Arom-C: [139.21 (CH, CH), 138.33 (C), 127.56 (CH, CH),
95.32 (C–I)], 25.40 (CH3); HRMS (m/z, ESI): M
+ 468.93,
[M+2] 470.93. Anal. Calcd. for C16H13ClIN5S (Mol. Wt.
469.73): C, 40.91; H, 2.79; N, 14.91. Found: C, 40.88; H,
2.77; N, 14.89%.
2.1.4.18. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(4-tosyl) hydrazine carbothioamide (7r). The reac-
tion mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
73% yield; m.p. 190–192 C; IR (cm1, KBr): 3240 (NH),
1218 (C‚S), 1572 (C‚N), 1610 (C‚C); 1H NMRatives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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6 S.M. Divatia et al.(400 MHz, DMSO-d6): d 2.38 (s, 3H, CH3), 2.51 (s, 3H, CH3),
7.28–7.74 (m, 6H, Ar-H) 7.98 (s, 1H, Ar-H), 8.23 (s, 1H, NH),
10.07 (s, 1H, NH), 12.23 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [152.46 (C), 140.62 (C),
137.74 (C), 130.55 (C–Cl), 126.64 (CH), 117.58 (CH), 116.70
(CH)], 184.28 (C‚S), 157.15 (N‚CH), Arom-C: [142.16
(C), 141.78 (C), 130.54 (CH, CH), 127.48 (CH, CH)], 35.65
(CH3), 25.46 (CH3); HRMS (m/z, ESI): M
+ 357.18, [M+2]
359.18. Anal. Calcd. for C17H16ClN5S (Mol. Wt. 357. 86): C,
57.06; H, 4.51; N, 19.57. Found: C, 57.00; H, 4.48; N, 19.55%.
2.1.4.19. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(2,3-dichlorophenyl) hydrazine carbothioamide (7s).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
68% yield; m.p. 182–184 C; IR (cm1, KBr): 3296 (NH),
1217 (C‚S), 1572 (C‚N), 1583 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 6.51–6.53 (d,
1H, J= 8 Hz, Ar-H), 7.15–7.17 (d, 1H, J= 7.9 Hz, Ar-H),
7.19–8.30 (m, 3H, Ar-H), 8.48 (s, 1H, Ar-H), 9.55 (s, 1H,
NH), 10.41 (s, 1H, NH), 12.92 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [152.34 (C),
140.69 (C), 137.77 (C), 130.54 (C–Cl), 126.69 (CH), 117.63
(CH), 116.74 (CH)], 184.16 (C‚S), 157.22 (N‚CH), Arom-
C: [139.03 (C), 138.36 (C–Cl), 134.54 (C–Cl), 134.50 (CH),
133.22 (CH), 130.47 (CH)], 25.55 (CH3); HRMS (m/z, ESI):
M+ 411.92, [M+2] 413.92. Anal. Calcd. for C16H12Cl3N5S
(Mol. Wt. 412.72): C, 46.56; H, 2.93; N, 16.97. Found: C,
46.54; H, 2.90; N, 16.95%.
2.1.4.20. (E)-2-[1-(5-Chloro-1H-benzo[d]imidazol-2-yl)ethyl-
idene] N-(3,4-dichlorophenyl) hydrazine carbothioamide (7t).
The reaction mass was heated in MW at 180 W with a total
irradiation time of 30 min. The product was a brown solid;
65% yield; m.p. 183–184 C; IR (cm1, KBr): 3321 (NH),
1217 (C‚S), 1581 (C‚N), 1618 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 7.31–7.33 (d,
1H, J= 7.9 Hz, Ar-H), 7.54–7.83 (m, 4H, Ar-H), 8.46 (s,
1H, Ar-H), 9.65 (s, 1H, NH), 10.02 (s, 1H, NH), 12.52 (s,
1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benzimidazole
C: [152.56(C), 140.75 (C), 137.80 (C), 130.55 (C–Cl), 126.71
(CH), 117.68 (CH), 116.77 (CH)], 184.32 (C‚S), 157.30
(N‚CH), Arom-C: [139.12 (C), 138.39 (CH), 134.58 (C–Cl),
133.42 (C–Cl), 133.12 (CH), 126.03 (CH)], 25.42 (CH3);
HRMS (m/z, ESI): M+ 411.95, [M+2] 413.95. Anal. Calcd.
for C16H12Cl3N5S (Mol. Wt. 412.72): C, 46.56; H, 2.93; N,
16.97. Found: C, 46.54; H, 2.90; N, 16.95%.
2.1.5. General procedure illustrating the synthesis of (E)-2-[1-
(1H-benzo[d]imidazol-2-yl)ethylidene] N-hydrazine
carbothioamide (8a–8t)
Another series of compounds (8a–8t) were also synthesized
and puriﬁed similarly by the general method described in Sec-
tion 2.1.4, taking compound 4b as a starting material. (Refer
Scheme 1).
2.1.5.1. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethyli-
dene]hydrazine carbothioamide (8a). The reaction mass was
heated in MW at 180 W with a total irradiation time of
25 min. The product was a light brown solid; 77% yield;
m.p. 216 C; IR (cm1, KBr): 3354 (NH), 1215 (C‚S), 1535Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09(C‚N), 1596 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
2.48 (s, 3H, CH3), 7.16–7.18(d, 1H, J= 8 Hz, Ar-H), 7.39–
7.42 (d, 1H, J= 8.5 Hz, Ar-H), 7.77–7.95 (m, 2H, Ar-H),
8.64 (s, 2H, NH2), 10.70 (s, 1H, NH), 12.86 (s, 1H, NH).
13C
NMR (100 MHz, DMSO-d6): d Benzimidazole C: [153.24
(C), 136.25 (C, C), 128.57 (CH, CH), 118.63 (CH, CH)],
178.19 (C‚S), 157.35 (N‚CH), 25.24 (CH3); HRMS (m/z,
ESI): M+ 233.03, [M+1] 234.03. Anal. Calcd. for
C10H11N5S (Mol. Wt. 233.29): C, 51.48; H, 4.75; N, 30.02.
Found: C, 51.42; H, 4.70; N, 29.98.%.
2.1.5.2. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
phenyl hydrazine carbothioamide (8b). The reaction mass was
heated in MW at 180 W with a total irradiation time of
30 min. The product was a brown color solid in 82% yield
and m.p. at 165–167 C; IR (cm1, KBr): 3225 (NH), 1202
(C‚S), 1519 (C‚N), 1599 (C‚C); 1H NMR (400 MHz,
DMSO-d6): d 2.48 (s, 3H, CH3), 7.27–7.29 (d, 1H,
J= 7.9 Hz, Ar-H), 7.40–7.44 (t, 1H, J= 7.5 Hz, Ar-H),
7.51–7.54 (d, 1H, J= 8.5 Hz, Ar-H), 7.59–7.62 (d, 1H,
J= 8 Hz, Ar-H), 8.35–8.37 (d, 1H, J= 8 Hz, Ar-H), 10.38
(s, 1H, NH), 11.07 (s, 1H, NH), 13.05 (s, 1H, NH). 13C
NMR (100 MHz, DMSO-d6): d Benzimidazole C: [153.28
(C), 136.30 (C, C), 128.60 (CH, CH), 118.68 (CH, CH)],
185.14 (C‚S), 157.44 (N‚CH), Arom-C: [140.10 (C),
132.33 (CH, CH), 130.67 (CH), 127.46 (CH)], 25.36 (CH3);
HRMS (m/z, ESI): M+ 309.12, [M+1] 310.13. Anal. Calcd.
for C16H15N5S (Mol. Wt. 309.38): C, 62.11; H, 4.89; N,
22.64. Found: C, 62.08; H, 4.85; N, 22.62%.
2.1.5.3. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
ethyl hydrazine carbothioamide (8c). The reaction mass was
heated in MW at 180 W with a total irradiation time of
25 min. The product was a brown solid; 69% yield; m.p.
226–228 C; IR (cm1, KBr): 3437 (NH), 1213 (C‚S), 1525
(C‚N), 1589 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
2.50 (s, 3H, CH3), 1.14–1.22 (t, 3H, J= 8 Hz, CH 3), 3.59–
3.92 (m, 2H, CH2) 7.20–7.82 (m, 4H, Ar-H), 9.01 (s, 1H,
NH), 10.68 (s, 1H, NH), 12.69 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [151.69 (C),
136.45 (C, C), 128.65 (CH, CH), 118.73 (CH, CH)], 178.31
(C‚S), 157.48 (N‚CH), 46.07 (CH2), 28.49 (CH3), 25.46
(CH3); HRMS (m/z, ESI): M
+ 261.11, [M+1] 262.11. Anal.
Calcd. for C12H15N5S (Mol. Wt. 261.34): C, 55.15; H, 5.79;
N, 26.80. Found: C, 55.13; H, 5.76; N, 26.78%.
2.1.5.4. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(n-butyl) hydrazine carbothioamide (8d). The reaction mass
was heated in MW at 180 W with a total irradiation time of
25 min. The product was a brown solid; 68% yield; m.p.
210 C; IR (cm1, KBr): 3453 (NH), 1216 (C‚S), 1419
(C‚N), 1541 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
1.26–1.97 (m, 5H, CH3CH2), 2.46 (s, 3H, CH 3), 4.03–4.45
(m, 2H, CH2), 7.21–7.68 (m, 6H, Ar-H), 8.98 (s, 1H, NH),
10.65 (s, 1H, NH), 12.78 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [151.72 (C), 136.50 (C, C),
128.70 (CH, CH), 118.78 (CH, CH)], 178.71 (C‚S), 157.56
(N‚CH), n-butyl:[46.22 (CH2), 35.79 (CH2), 30.66 (CH2),
25.39 (CH3)], 25.43 (CH3); HRMS (m/z, ESI): M
+ 289.14,
[M+1] 290.14. Anal. Calcd. for C14H19N5S (Mol. Wt.
289.39): C, 58.10; H, 6.62; N, 24.20. Found: C, 58.02; H,
6.60; N, 24.15%.atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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Green synthesis of thiosemicarbazone derivatives 72.1.5.5. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
cyclohexyl hydrazine carbothioamide (8e). The reaction mass
was heated in MW at 180 W with a total irradiation time of
25 min. The product was a brown solid; 72% yield; m.p.
214 C; IR (cm1, KBr): 3369 (NH), 1211 (C‚S), 1500
(C‚N), 1581 (C‚C); 1H NMR (400 MHz, DMSO-d6):d
1.26–1.91 (m, 11H, cyclohex), 2.50 (s, 3H, CH 3), 7.21–7.24
(d, 1H, J= 7.9 Hz, Ar-H), 7.51–7.54 (d, 1H, J= 8.5 Hz,
Ar-H), 7.68–7.70 (d, 1H, J= 8 Hz, Ar-H), 8.58 (s, 1H, NH),
10.53 (s, 1H, NH), 12.76 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [151.74 (C), 136.54 (C, C),
128.75 (CH, CH), 118.80 (CH, CH)], 178.77 (C‚S), 157.66
(N‚CH), cyclohexyl C:[60.21 (C), 45.66 (CH2,CH2)], 36.32
(CH2), 30.33 (CH2, CH2)], 25.45 (CH3); HRMS (m/z, ESI):
M+ 315.15, [M+1] 316.15. Anal. Calcd. for C16H21N5S
(Mol. Wt. 315.43): C, 60.92; H, 6.71; N, 22.20. Found: C,
60.90; H, 6.68; N, 22.15.%.
2.1.5.6. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-chlorophenyl) hydrazine carbothioamide (8f). The reaction
mass was heated in MW at 180 W with a total irradiation time
of 30 min. The product was a brown solid; 62% yield; m.p.
175–176 C; IR (cm1, KBr): 3458 (NH), 1201 (C‚S), 1541
(C‚N), 1597 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
2.50 (s, 3H, CH3), 7.10–7.12 (d, 1H, J= 8 Hz, Ar-H), 7.21–
7.70 (m, 6H, Ar-H), 9.24 (s, 1H, NH), 11.23 (s, 1H, NH),
13.03 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benz-
imidazole C: [151.72 (C), 136.59 (C, C), 128.70 (CH, CH),
118.75 (CH, CH)], 185.07 (C‚S), 157.46 (N‚CH), Arom-C:
[140.23 (C), 135.67 (C–Cl), 130.12 (CH, CH), 128.88 (CH,
CH)], 25.48 (CH3); HRMS (m/z, ESI): M
+ 343.07, [M+2]
345.07. Anal. Calcd. for C16H14ClN5S (Mol. Wt. 343.83): C,
55.89; H, 4.10; N, 20.37. Found: C, 55.85; H, 4.05; N, 20.35%.Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.092.1.5.7. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-nitrophenyl) hydrazine carbothioamide (8g). The reaction
mass was heated in MW at 180 W with a total irradiation time
of 30 min. The product was a brown solid; 60% yield; m.p.
204–206 C; IR (cm1, KBr): 3203 (NH), 1199 (C‚S), 1546
(C‚N), 1595 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
2.56 (s, 3H, CH3), 7.12–7.15 (d, 1H, J= 8.9 Hz, Ar-H),
7.23–7.26 (d, 1H, J= 9 Hz, Ar-H), 7.72–7.75 (d, 1H,
J= 8.9 Hz, Ar-H), 7.85–7.88 (d, 1H, J= 8.9 Hz, Ar-H),
8.17–8.20 (d, 1H, J= 8 Hz, AR-H), 9.63 (s, 1H, NH), 10.67
(s, 1H, NH), 12.94 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [151.78 (C), 136.63 (C, C),
128.74 (CH, CH), 118.81 (CH, CH)], 185.16 (C‚S), 157.55
(N‚CH), Arom-C: [150.06 (C), 152.27 (C–NO2), 130.22
(CH, CH), 130.58 (CH, CH)], 25.51 (CH3); HRMS (m/z,
ESI): M+ 354.08, [M+1] 355.08. Anal. Calcd. for C16H14N6-
O2S (Mol. Wt. 354.38): C, 54.23; H, 3.98; N, 23.71. Found:
C, 54.20; H, 3.95; N, 23.66%.
2.1.5.8. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-methoxyphenyl) hydrazine carbothioamide (8h). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 30 min. The product was a brown solid; 78% yield;
m.p. 196–198 C; IR (cm1, KBr): 3444 (NH), 1202 (C‚S),
1539 (C‚N), 1602 (C‚C), 1249 (C–O–C); 1H NMR
(400 MHz, DMSO-d6): d 2.51 (s, 3H, CH3), 3.79 (s, 3H,
OCH3), 6.51–6.55 (d, 1H, J= 9.5 Hz, Ar-H), 7.01–7.05 (d,
1H, J= 9.5 Hz, Ar-H), 7.20–7.24 (d, 1H, J= 9.5 Hz, Ar-H),
7.66–7.68 (d, 1H, J= 8 Hz, Ar-H), 8.62–8.84 (d, 1H,
J= 8 Hz, Ar-H), 10.38 (s, 1H, NH), 11.01 (s, 1H, NH),
12.87 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benz-
imidazole C: [151.75 (C), 136.65 (C, C), 128.76 (CH, CH),
118.75 (CH, CH)], 185.34 (C‚S), 157.59 (N‚CH), Arom-C:atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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8 S.M. Divatia et al.[162.45 (C–OCH3), 142.37 (C), 130.28 (CH, CH), 120.08 (CH,
CH)], 58.50 (OCH3), 25.54 (CH3); HRMS (m/z, ESI): M
+
339.12, [M+1] 340.12. Anal. Calcd. for C17H17ON5S (Mol.
Wt. 339.39): C, 60.16; H, 5.05; N, 20.63. Found: C, 60.10;
H, 4.98; N, 20.60%.
2.1.5.9. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(isopropyl) hydrazine carbothioamide (8i). The reaction mass
was heated in MW at 180 W with a total irradiation time of
25 min. The product was a brown solid; 75% yield; m.p.
224–226 C; IR (cm1, KBr): 3448 (NH), 2978(C(CH3)),
1211 (C‚S), 1498 (C‚N), 1530 (C‚C); 1H NMR
(400 MHz, DMSO-d6): d 1.30–1.33 (d, 6H, J= 9.5 Hz, (CH
3)2), 2.50 (s, 3H, CH3), 4.36–4.64 (m, 1H, CH), 7.12–7.69 (m,
4H, Ar-H), 8.61 (s, 1H, NH), 10.68 (s, 1H, NH), 12.78 (s,
1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benzimidazole
C: [151.77 (C), 136.62 (C, C), 128.72 (CH, CH), 118.78 (CH,
CH)], 179.33 (C‚S), 157.60 (N‚CH), iso-propyl-C:[58.67
(CH), 36.56 (CH3,CH3)], 25.56 (CH3); HRMS (m/z, ESI):
M+ 275.10, [M+1] 276.10. Anal. Calcd. for C13H17N5S
(Mol. Wt. 275.37): C, 56.70; H, 6.22; N, 25.43. Found: C,
56.67; H, 6.19; N, 25.40%.
2.1.5.10. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(tert-butyl) hydrazine carbothioamide (8j). The reaction mass
was heated in MW at 180 W with a total irradiation time of
25 min. The product was a brown solid; 72% yield; m.p.
220–222 C; IR (cm1, KBr): 3381 (NH), 1230 (C‚S), 1514
(C‚N), 1560 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
1.37–1.71 (m, 9H, (CH3)3), 2.50 (s, 3H, CH3), 7.12–7.98 (m,
8H, Ar-H), 8.45–8.48 (d, 1H, J= 8.5 Hz, Ar-H), 10.28 (s,
1H, NH), 12.82 (s, 1H, NH), 13.78 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [151.67 (C),
136.60 (C, C), 128.68 (CH, CH), 118.73 (CH, CH)], 179.27
(C‚S), 157.55 (N‚CH), t-butyl-C:[65.20 (C), 32.48
(CH3,CH3,CH3)], 25.52 (CH3); HRMS (m/z, ESI): M
+
289.14, [M+1] 290.14. Anal. Calcd. for C14H19N5S (Mol.
Wt. 289.39): C, 58.10; H, 6.62; N, 24.20. Found: C, 58.05;
H, 6.60; N, 24.18%.
2.1.5.11. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(benzyl) hydrazine carbothioamide (8k). The reaction mass
was heated in MW at 180 W with a total irradiation time of
35 min. The product was a brown solid; 60% yield; m.p.
219–220 C; IR (cm1, KBr): 3383 (NH), 1211 (C‚S), 1523
(C‚N), 1573 (C‚C); 1H NMR (400 MHz, DMSO-d6): d
2.50 (s, 3H, CH3), 4.28–4.45 (m, 2H, CH2), 7.21–7.69 (m,
4H, Ar-H), 8.43–8.58 (d, 1H, J= 9.5 Hz, Ar-H), 9.05 (s, 1H,
NH), 10.53 (s, 1H, NH), 12.77 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [151.68 (C),
136.66 (C, C), 128.70 (CH, CH), 118.75 (CH, CH)], 183.30
(C‚S), 157.58 (N‚CH), Arom-C: [142.35 (C), 132.38 (CH,
CH), 131.65 (CH, CH), 130.85 (CH)], 55.08 (CH2), 25.32
(CH3); HRMS (m/z, ESI): M
+ 323.12, [M+1] 324.12. Anal.
Calcd. for C17H17N5S (Mol. Wt. 323.41): C, 63.13; H, 5.30;
N, 21.65. Found: C, 63.10; H, 5.25; N, 21.62%.
2.1.5.12. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(2,4-dichlorophenyl) hydrazine carbothioamide (8l). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 35 min. The product was a brown solid; 68% yield;
m.p. 185–187 C; IR (cm1, KBr): 3389 (NH), 1240 (C‚S),Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.091545 (C‚N), 1583 (C‚C); 1H NMR (400 MHz, DMSO-
d6):d 2.50 (s, 3H, CH3), 7.28–7.81 (m, 5H, Ar-H), 8.39 (d,
1H, Ar-H), 9.55 (s, 1H, Ar-H), 10.39 (s, 1H, NH), 11.39 (s,
1H, NH), 12.77 (s, 1H, NH). 13C NMR (100 MHz, DMSO-
d6): d Benzimidazole C: [151.62 (C), 136.56 (C, C), 128.72
(CH, CH), 118.77 (CH, CH)], 185.40 (C‚S), 157.68 (N‚CH),
Arom-C: [138.15 (C), 137.43 (C–Cl), 136.85 (CH), 135.65 (C–
Cl), 134.88 (CH), 126.25 (CH)], 25.44 (CH3); HRMS (m/z,
ESI): M+ 377.57, [M+2] 379.57. Anal. Calcd. for C16H13Cl2-
N5S (Mol. Wt. 378.27): C, 50.80; H, 3.46; N, 18.51. Found: C,
50.75; H, 3.43; N, 18.45%.
2.1.5.13. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(2-methoxyphenyl) hydrazine carbothioamide (8m). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 30 min. The product was a brown solid; 65% yield;
m.p. 194–196 C; IR (cm1, KBr): 3296 (NH), 1242 (C‚S),
1575 (C‚N), 1599 (C‚C), 1275 (C–O–C); 1H NMR
(400 MHz, DMSO-d6):d 2.50 (s, 3H, CH3), 3.84 (s, 3H,
OCH3), 6.63–7.65 (d, 1H, J= 8 Hz, Ar-H), 7.13–7.89 (m,
1H, Ar-H), 7.93–7.95 (d, 1H, J= 7.9 Hz, Ar-H), 7.95–7.99
(t, 1H, J= 7.9 Hz, Ar-H), 8.02–8.06 (d, 1H, J= 8 Hz, Ar-
H), 8.13–8.32 (d, 1H, J= 8.5 Hz, Ar-H), 8.53–8.76 (d, 1H,
J= 8.2 Hz, Ar-H), 9.84 (s, 1H, NH), 10.47 (s, 1H, NH),
12.83 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benz-
imidazole C: [151.65 (C), 136.52 (C, C), 128.77 (CH, CH),
118.79 (CH, CH)], 185.57 (C‚S), 157.71 (N‚CH), Arom-C:
[160.44 (C–OCH3), 135.13 (CH), 134.84 (C), 134.18 (CH),
130.56 (CH), 120.24 (CH)], 62.45 (OCH3), 25.56 (CH3);
HRMS (m/z, ESI): M+ 339.16, [M+1] 340.16. Anal. Calcd.
for C17H17ON5S (Mol. Wt. 339.41): C, 60.16; H, 5.05; N,
20.63. Found: C, 60.14; H, 5.00; N, 20.60%.
2.1.5.14. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(3-methoxyphenyl) hydrazine carbothioamide (8n). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 30 min. The product was a brown solid; 69% yield; m.p.
194–196 C; IR (cm1, KBr): 3273 (NH), 1195 (C‚S), 1576
(C‚N), 1598 (C‚C), 1280 (C–O–C); 1H NMR (400 MHz,
DMSO-d6):d 2.50 (s, 3H, CH3), 3.80 (s, 3H, CH3), 6.66 (d,
1H, J= 7.9 Hz, Ar-H), 6.88 (d, 1H, J= 8.5 Hz, Ar-H),
7.13–7.70 (m, 6H, Ar-H), 9.17 (s, 1H, NH), 10.42 (s, 1H,
NH), 11.08 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d
Benzimidazole C: [151.45 (C), 136.48 (C, C), 128.72 (CH,
CH), 118.74 (CH, CH)], 185.53 (C‚S), 157.65 (N‚CH),
Arom-C: [163.58 (C–OCH3), 140.22 (C), 132.68 (CH), 120.13
(CH), 118.55 (CH), 116.45 (CH)], 65.20 (OCH3), 25.36
(CH3); HRMS (m/z, ESI): M
+ 339.09, [M+1] 340.09. Anal.
Calcd. for C17H17ON5S (Mol. Wt. 339.41): C, 60.16; H, 5.05;
N, 20.63. Found: C, 60.14; H, 5.00; N, 20.60%.
2.1.5.15. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(benzoyl) hydrazine carbothioamide (8o). The reaction mass
was heated in MW at 180 W with a total irradiation time of
35 min. The product was a brown solid; 60% yield; m.p.
205–207 C; IR (cm1, KBr): 3145 (NH), 1228 (C‚S), 1580
(C‚N), 1612 (C‚C), 1725(C‚O); 1H NMR (400 MHz,
DMSO-d6):d 2.51 (s, 3H, CH3), 7.14–7.92 (m, 5H, Ar-H),
8.02 (d, 1H, J= 8 Hz, Ar-H), 9.87 (s, 1H, NH), 13.74 (s,
1H, NH), 13.86 (s, 1H, NH). 13C NMR (100 MHz, DMSO-
d6): d Benzimidazole C: [151.48 (C), 136.52 (C, C), 128.75
(CH, CH), 118.78 (CH, CH)], 185.44 (C‚S), 172.45 (C‚O),atives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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Green synthesis of thiosemicarbazone derivatives 9157.62 (N‚CH), Arom-C: [139.33 (C), 138.11 (CH), 132.65
(CH, CH), 131.83 (CH, CH)], 25.46 (CH3); HRMS (m/z,
ESI): M+ 337.14, [M+1] 338.14. Anal. Calcd. for
C17H15ON5S (Mol. Wt. 337.39): C, 60.52; H, 4.48; N, 20.76.
Found: C, 60.49; H, 4.45; N, 20.73%.
2.1.5.16. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-ﬂuorophenyl) hydrazine carbothioamide (8p). The reaction
mass was heated in MW at 180 W with a total irradiation time
of 35 min. The product was a brown solid; 73% yield; m.p.
198–199 C; IR (cm1, KBr): 3313 (NH), 1213 (C‚S), 1548
(C‚N), 1583 (C‚C); 1H NMR (400 MHz, DMSO-d6):d
2.51 (s, 3H, CH3), 6.68 (d, 1H, J= 7.5 Hz, Ar-H), 7.12 (d,
1H, J= 8 Hz, Ar-H), 7.46–7.98 (m, 4H, Ar-H), 9.16 (s, 1H,
NH), 10.25 (s, 1H, NH), 13.03 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [151.52 (C),
136.60 (C, C), 128.80 (CH, CH), 118.82 (CH, CH)], 185.53
(C‚S), 157.65 (N‚CH), Arom-C: [166.23 (C–F), 138.33
(C), 132.12 (CH, CH), 118.89 (CH, CH)], 25.56 (CH3); HRMS
(m/z, ESI): M+ 327.10, [M+1] 328.10. Anal. Calcd. for
C16H14FN5S (Mol. Wt. 327.37): C, 58.70; H, 4.31; N, 21.39.
Found: C, 58.65; H, 4.27; N, 21.36%.
2.1.5.17. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-iodophenyl) hydrazine carbothioamide (8q). The reaction
mass was heated in MW at 180 W with a total irradiation time
of 35 min. The product was a brown solid; 75% yield; m.p.
197–199 C; IR(cm1, KBr): 3294 (NH), 1202 (C‚S), 1548
(C‚N), 1596 (C‚C); 1H NMR (400 MHz, DMSO-d6):d
2.50 (s, 3H, CH3), 6.41–6.44 (d, 1H, J= 9 Hz, Ar-H), 7.12–
7.80 (m, 5H, Ar-H), 9.25 (s, 1H, NH), 10.43 (s, 1H, NH),
12.94 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): d Benz-
imidazole C: [151.45 (C), 136.67 (C, C), 128.82 (CH, CH),
118.85 (CH, CH)], 185.48 (C‚S), 157.63 (N‚CH), Arom-C:
[143.22 (CH, CH), 142.97 (C), 134.49 (CH, CH), 95.77
(C–I)], 25.67 (CH3); HRMS (m/z, ESI): M
+ 435.02, [M+1]
436.02. Anal. Calcd. for C16H14IN5S (Mol. Wt. 435.28): C,
44.15; H, 3.24; N, 16.09. Found: C, 44.10; H, 3.22; N, 16.02%.
2.1.5.18. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(4-tosyl) hydrazine carbothioamide (8r). The reaction mass
was heated in MW at 180 W with a total irradiation time of
30 min. The product was a brown solid; 70% yield; m.p.
195–197 C; IR (cm1, KBr): 3298 (NH), 1234 (C‚S), 1548
(C‚N), 1585 (C‚C); 1H NMR (400 MHz, DMSO-d6):d
2.37 (s, 3H, CH3), 2.51 (s, 3H, CH3), 7.10–7.48 (m, 1H, Ar-
H), 7.68–7.72 (d, 1H, J= 9 Hz, Ar-H), 7.79 (d, 1H,
J= 7.9 Hz, Ar-H), 7.89 (d, 1H, J= 7.9 Hz, Ar-H), 9.12 (s,
1H, NH), 10.15 (s, 1H, NH), 12.34 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6): d Benzimidazole C: [151.48 (C),
136.68 (C, C), 128.78 (CH, CH), 118.82 (CH, CH)], 185.54
(C‚S), 157.62 (N‚CH), Arom-C: [142.32 (C–CH3), 135.67
(C), 130.56 (CH, CH), 126.47 (CH, CH)], 32.46 (CH3), 25.67
(CH3); HRMS (m/z, ESI): M
+ 323.06, [M+1] 324.06. Anal.
Calcd. for C17H17N5S (Mol. Wt. 323.41): C, 63.13; H, 5.30;
N, 21.65. Found: C, 63.10; H, 5.25; N, 21.63%.
2.1.5.19. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(2,3-dichlorophenyl) hydrazine carbothioamide (8s). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 35 min. The product was a brown solid; 66% yield;Please cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09m.p. 185–187 C; IR (cm1, KBr): 3246 (NH), 1180 (C‚S),
1533 (C‚N), 1594 (C‚C); 1H NMR (400 MHz, DMSO-
d6):d 2.5 (s, 3H, CH3), 7.12 (d, 1H, J= 8.9 Hz, Ar-H), 7.35
(d, 1H, J= 9.5 Hz, Ar-H), 7.43 (d, 1H, J= 9 Hz, Ar-H),
8.27 (d, 1H, J= 8.9 Hz, Ar-H), 9.70 (s, 1H, NH), 10.38 (s,
1H, NH), 12.92 (s, 1H, NH). 13C NMR (100 MHz, DMSO-
d6): d Benzimidazole C: [151.52 (C), 136.70 (C, C), 128.76
(CH, CH), 118.81 (CH, CH)], 185.59 (C‚S), 157.66 (N‚CH),
Arom-C: [142.18 (C), 141.35 (C–Cl), 140.73 (C–Cl), 139.97
(CH), 135.05 (CH), 130.28 (CH)], 25.66 (CH3); HRMS (m/z,
ESI): M+ 377.37, [M+2] 379.38. Anal. Calcd. for C16H13Cl2-
N5S (Mol. Wt. 378.27): C, 50.80; H, 3.46; N, 18.51. Found: C,
50.75; H, 3.43; N, 18.47%.
2.1.5.20. (E)-2-[1-(1H-Benzo[d]imidazol-2-yl)ethylidene] N-
(3,4-dichlorophenyl) hydrazine carbothioamide (8t). The reac-
tion mass was heated in MW at 180 W with a total irradiation
time of 35 min. The product was a brown solid; 68% yield;
m.p. 186–188 C; IR (cm1, KBr): 3296 (NH), 1213 (C‚S),
1566 (C‚N), 1598 (C‚C); 1H NMR (400 MHz, DMSO-
d6):d 2.50 (s, 3H, CH3), 6.52–6.54 (d, 1H, J= 8 Hz, Ar-H),
6.84 (d, 1H, J= 8 Hz, Ar-H), 7.17–7.98 (m, 4H, Ar-H),
8.07–8.10 (d, 1H, J= 8.5 Hz, Ar-H), 9.40 (s, 1H, NH), 10.04
(s, 1H, NH), 12.56 (s, 1H, NH). 13C NMR (100 MHz,
DMSO-d6): d Benzimidazole C: [151.57 (C), 136.74 (C, C),
128.79 (CH, CH), 118.77 (CH, CH)], 185.62 (C‚S), 157.68
(N‚CH), Arom-C: [140.35 (C), 139.69 (CH), 135.85 (C–Cl),
135.25 (C–Cl), 135.08 (CH), 125.18 (CH)], 25.58 (CH3);
HRMS (m/z, ESI): M+ 377.45, [M+2] 379.47. Anal. Calcd.
for C16H13Cl2N5S (Mol. Wt. 378.27): C, 50.80; H, 3.46; N,
18.51. Found: C, 50.75; H, 3.43; N, 18.47%.
2.2. Anti-malarial activity
2.2.1. Sample preparation
A stock solution of 5 mg/mL of each of the test samples as well
as standards was prepared in DMSO and subsequent dilutions
were prepared with the culture medium. The diluted samples in
20 ll volume were added to the test wells so as to obtain ﬁnal
concentrations (at ﬁve fold dilutions) ranging between 0.4 and
100 lg/mL in duplicate well containing parasitized cell
preparation.
2.2.2. Assay for in vitro antimalarial activity
The in vitro antimalarial assay was carried out in 96 well
microtitre plates according to the microassay protocol of
Reickmann and co-workers (1978) with minor modiﬁcations.
The cultures of P. falciparum strain were maintained in
medium RPMI 1640 supplemented with 25 mM HEPES, 1%
D-glucose, 0.23% sodium bicarbonate and 10% heat inacti-
vated human serum. The asynchronous parasites of P. falcipa-
rum were synchronized after 5% D-sorbitol treatment to obtain
only the ring stage parasitized cells. For carrying out the assay,
an initial ring stage parasitaemia of 0.8–1.5% at 3% haemato-
crit in a total volume of 200 ll of medium RPMI-1640 was
determined by Jaswant Singh Bhattacharya (JSB) staining
(Singh, 1956) to assess the percent parasitaemia (rings) and
uniformly maintained with 50% RBCs (O+ve). The culture
plates were incubated at 37 C in a candle jar. After 36–40 h
incubation, thin blood smears from each well were preparedatives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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Table 1 List of thiosemicarbazone derivatives with structural variation and their IC50 values.
Entry X R Product IC50 (lg/mL) Entry X R Product IC50 (lg/mL)
1 Cl H 7a* 0.095 21 H H 8a 0.088
2 Cl Ph 7b* 0.87 22 H Ph 8b 0.83
3 Cl Et 7c* 0.72 23 H Et 8c 0.65
4 Cl n-But 7d* 0.75 24 H n-But 8d 0.72
5 Cl C6H11 7e
* 0.047 25 H C6H11 8e 0.056
6 Cl 4-ClC6H4 7f 0.26 26 H 4-ClC6H4 8f 1.56
7 Cl 4-(O2N)C6H4 7g 0.098 27 H 4-(O2N)C6H4 8g 0.42
8 Cl 4-MeOC6H4 7h 0.15 28 H 4-MeOC6H4 8h 0.073
9 Cl iso-Pr 7i 0.42 29 H iso-Pr 8i 0.057
10 Cl tert-But 7j 0.98 30 H tert-But 8j 1.12
11 Cl CH2C6H5 7k 0.093 31 H CH2C6H5 8k 0.97
12 Cl 2,4-ClC6H3 7l 0.68 32 H 2,4-ClC6H3 8l 1.47
13 Cl 2-MeOC6H4 7m 1.33 33 H 2-MeOC6H4 8m 0.54
14 Cl 3-MeOC6H4 7n 1.89 34 H 3-MeOC6H4 8n 0.096
15 Cl COC6H5 7o 0.023 35 H COC6H5 8o 0.93
16 Cl 4-FC6H4 7p 0.003 36 H 4-FC6H4 8p 0.64
17 Cl 4-IC6H4 7q 0.012 37 H 4-IC6H4 8q 1.47
18 Cl 4-MeC6H4 7r 0.025 38 H 4-MeC6H4 8r 1.33
19 Cl 2.3-ClC6H3 7s 0.005 39 H 2.3-ClC6H3 8s 0.90
20 Cl 3,4-ClC6H3 7t 0.56 40 H 3,4-ClC6H3 8t 0.45
* Already reported compounds by Patel et al. (2013). Standards taken for antimalarial activity: chloroquine (0.020 lg/mL) and quinine
(0.268 lg/mL).
10 S.M. Divatia et al.and stained with JSB stain. The slides were microscopically
observed to record maturation of the ring stage parasites into
trophozoites and schizonts in the presence of different concen-
trations of the test agents. The test concentration which inhib-
ited the complete maturation into schizonts was recorded as
the minimum inhibitory concentration (MIC). Chloroquine
and Quinine were used as the reference drugs.3. Results and discussion
In the present work, thiosemicarbazone derivatives containing
the benzimidazole moiety were prepared according to reaction
as in Scheme 1. The condensation reaction between commer-
cially available substituted benzene-1,2-diamine (2a–2b) with
lactic acid (1) gives 1-(substituted-1H-benzimidazol-yl) ethanol
(3a–3b) (refer Scheme 1) in quantitative yield. Originally, this
reaction was performed conventionally for 4 h in a nitrogen
environment at 140–150 C (Mylonas and Mamalis, 2005).
Patel et al. (2013) had developed this reaction in microwave
where they gave microwave irradiation at 140 C (300 W).
Due to this compounds (3a–3b) were synthesized in 35 min
only without any by-products. An introduction of ethylene
glycol in reaction mass was justiﬁed for the temperature
enhancement (because of its high dielectric constant of 38.66)
during the reaction so that reaction could reach its optimum
temperature within the short period of time. The IR spectra
of compounds (3a–3b) showed sharp absorption bands,
appearing between 3350 and 3430 cm1, was attributed to
the NH function of compounds and other, observed between
1111 and 1130 cm1, was assigned to C–O stretching fre-
quency. The 1H NMR spectrum of compounds (3a–3b) exhib-
ited two different signals between 5.60 and 5.80 ppm (OH) and
near 13.0 ppm (NH), respectively. The signals of aromatic pro-
ton of compound were observed between 7.14 and 8.54 ppm.
Further oxidation of the sec-alcohol (3a–3b) gave the corre-
sponding ketone (4a–4b) (refer Scheme 1). Here, we usedPlease cite this article in press as: Divatia, S.M. et al., Novel thiosemicarbazone deriv
ity. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.09bleach, which is a cheap, nontoxic reagent whose active com-
ponent sodium hypochlorite (NaOCl) is an excellent oxidizing
agent, instead of original reagent chromium trioxide (CrO3). In
earlier reported method (Patel et al., 2013) the product loss
was occurring due to the usage of CrO3 which has overcome
by using NaOCl as an oxidizing agent in mild acidic condition
also the previous harmful waste product has been taken care
by this change. The spectral data of 4a–4b showed IR band
near 1670 cm1 conﬁrming the formation of ketone (C‚O).
Further, 1H NMR of compounds 4a–4b shown the presence
of a singlet between 13.0 and 13.25 ppm indicating the amino
group present (NH), 7.28–8.50 ppm shown the presence of aro-
matic protons.
The N4-monosubstituted thiosemicarbazides (6a–6t) were
synthesized as outlined in Scheme 1. Previously, these com-
pounds were synthesized conventionally at room temperature
(Mylonas and Mamalis, 2005; Patel et al.). We have performed
this reaction under microwave irradiation which was more
rapid and gave ample amount of pure product. Thiosemicar-
bazides were formed from hydrazine and various isothiocya-
nates (5a–5t) which were commercially available in the
market (Mylonas and Mamalis, 2005). Patel et al. (2013) have
already synthesized 7a–7e by simple condensation reaction
between compound 4a and different thiosemicarbazides
(6a–6e). The time for this conventional condensation was
approx. 4 h. In this present work the method is modiﬁed by
usage of microwave irradiation to increase the rate of reaction.
A series of ﬁnal compounds 7a–7t were synthesized by conden-
sation reaction between compound 4a and 6a–6t, while 8a–8t
were synthesized by condensation reaction between compound
4b and 6a–6t. The product obtained from the reaction was at
its best purity without any by-products. Title compounds
7a–7t and 8a–8t showed IR bands at 3250–3460 cm1 which
conﬁrmed the formation of the benzimidazole ring which
was further substantiated with the help of 1H NMR data with
the peaks at 12.50–13.30 ppm and 9.20–10.98 ppm for the pro-
tons of the amino group. Peaks between 7.05 and 8.70 ppmatives containing benzimidazole moiety: Green synthesis and anti-malarial activ-
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Green synthesis of thiosemicarbazone derivatives 11were observed for respective aromatic protons. Synthesis of
ﬁnal compounds was also conﬁrmed by 13C NMR data, peaks
between 179 and 186 ppm have conﬁrmed the formation of
C‚S. Peaks between 115–165 and 25.20–25.65 ppm conﬁrmed
the presence of aromatic carbons and methyl carbon, respec-
tively. Title compounds were further conﬁrmed by mass spec-
tral data and elemental analysis.
The synthesized compounds 7a–7t and 8a–8t were screened
for their in vitro antimalarial activity against P. falciparum by
measuring the minimum inhibitory concentration (lg/mL) as
shown in Table 1, respectively. Compounds 7o (0.023 lg/
mL), 7p (0.003 lg/mL), 7q (0.012 lg/mL), 7r (0.025 lg/mL)
and 7s (0.005 lg/mL) against standard Chloroquine
(0.020 lg/mL) showed excellent activity. Compounds 7a
(0.095 lg/mL), 7e (0.047 lg/mL), 7g (0.098 lg/mL), 7k
(0.093 lg/mL), 8a (0.088 lg/mL), 8e (0.053 lg/mL), 8h
(0.073 lg/mL), 8i (0.057 lg/mL) and 8n (0.096 lg/mL) showed
moderate activity against Chloroquine (0.020 lg/mL). Com-
pounds 7f (0.26 lg/mL) and 7h (0.15 lg/mL) against standard
quinine (0.268 lg/mL) showed excellent activity, while remain-
ing compounds showed moderate to very less activity against
quinine (0.268 lg/mL). As structure activity relationship
(SAR) study of all compounds was taken into account, it was
observed that compounds having electron withdrawing func-
tional groups like chloro, ﬂuoro and iodo showed excellent activ-
ity. Compounds containing moderate electron releasing groups
like substituted methoxy exhibited good antimalarial potency.
The presence of some other groups like cyclohexyl and isopro-
pyl seems to be important for the antimalarial activity.
4. Conclusion
We have demonstrated that the thiosemicarbazone derivatives
7a–7t and 8a–8t can be synthesized by making modiﬁcations
in the reported method. The production was successful with less
time duration and improved quality and quantity than the old
method. Environmental issues are also resolved because of the
use of the microwave and the green oxidizing agent NaOCl
(Bleach) in the method. A common parameter was observed
between all active compounds that they all contained electron
withdrawing functional groups in theirmoiety. Among the com-
pounds tested 7o, 7p, 7q, 7r, 7s, 8a, 8e, 8i, 8n and 8h exhibited
good antimalarial activity in vitro. Finally, it is conceivable that
further derivatization of such compounds with high andmoder-
ate electron withdrawing functional groups will be of interest
with good hope to get more selective antimalarial agents.
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